The Center for Safe Internet Pharmacies strives to stay on top of the latest topics, trends and developments related to counterfeit online medicines and illegitimate internet pharmacies. This page will also be updated with CSIP happenings, as well as news from our members and ex-officio member.
Even before the United States entered into the era of the coronavirus illness (COVID-19), only 13 percent of the approximately 21 million people who needed treatment for a substance use disorder received it. Add to this the economic and social burdens facing Americans and this percentage has only likely decreased. With most states not covering a full panel of substance use disorder treatment through Medicaid, the response to opioid and other drug misuse has not been as strong as it could be. The American Rescue Plan may offer hope. Read More
Deaths from drug overdoses were on the rise, even prior to coronavirus disease 2019 (COVID-19). And the pandemic has only amplified the issue. According to the US Centers for Disease Control and Prevention (CDC), “over 81,000 drug overdose deaths occurred in the US in the 12 months ending in May 2020, the highest number of overdose deaths ever recorded in a 12-month period.” In response to pandemic-induced rising overdoses, the federal government and partners have amplified programs to support local communities. Read More
Did you know that in a 2019 survey by the American Board of Pain Medicine 92% of pain specialists “reported that they were required to submit a prior authorization for non-opioid pain care, which delayed patient treatment”? Non-opioid pain care includes occupational or physical therapy and non-opioid medications, treatments, creams, or patches. This barrier and more are what lead the American Medical Association (AMA) to recently recommend that states partner with universities and health systems to support “access to evidence-based interdisciplinary pain management delivery models” and that insurance companies review the coverage for these treatment protocols so they are on par with opioid coverage and patients are able to get the care they need. Read More